Sign in
4

Changes in Ownership

Yarrow Bioscience, Inc. Filed Acc 0001415889-25-015382

PRESIDENT AND CEO acquired 8,681 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Domzalski David · PRESIDENT AND CEO

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2025-06-02 Grant or award : show line 1 in the form +8,681 $0.81 $7,032 454,244 D
Loading xslF345X05/form4-06032025_040601.xml…